Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness

Pei Chi Hou, Yo Hua Li, Shih Chieh Lin, Shau Chieh Lin, Jenq Chang Lee, Bo Wen Lin, Jing Ping Liou, Jang Yang Chang, Ching Chuan Kuo, Yi Min Liu, H. Sunny Sun, Shaw Jenq Tsai

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Cancer stem-like cells (CSC) evolve to overcome the pressures of reduced oxygen, nutrients or chemically induced cell death, but the mechanisms driving this evolution are incompletely understood. Here, we report that hypoxia-mediated downregulation of the dual specificity phosphatase 2 (DUSP2) is critical for the accumulation of CSC in colorectal cancer. Reduced expression of DUSP2 led to overproduction of COX-2–derived prostaglandin E2, which promoted cancer stemness via the EP2/EP4 signaling pathways. Genetic and pharmacological inhibition of PGE2 biosynthesis or signal transduction ameliorated loss-of-DUSP2–induced tumor growth and cancer stemness. Genome-wide profile analysis revealed that genes regulated by DUSP2 were similar to those controlled by histone deacetylase. Indeed, treatment with novel histone deacetylase inhibitors abolished hypoxia-induced DUSP2 downregulation, COX-2 overexpression, cancer stemness, tumor growth, and drug resistance. Our findings illuminate mechanisms of cancer stemness and suggest new cancer therapy regimens.

Original languageEnglish
Pages (from-to)4305-4316
Number of pages12
JournalCancer Research
Volume77
Issue number16
DOIs
Publication statusPublished - Aug 15 2017

Fingerprint

Dual-Specificity Phosphatases
Dual Specificity Phosphatase 2
Colonic Neoplasms
Down-Regulation
Neoplasms
Neoplastic Stem Cells
Dinoprostone
Histone Deacetylase Inhibitors
Histone Deacetylases
Growth
Hypoxia
Drug Resistance
Colorectal Neoplasms
Signal Transduction
Cell Death
Genome
Pharmacology
Oxygen
Pressure
Food

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Hou, P. C., Li, Y. H., Lin, S. C., Lin, S. C., Lee, J. C., Lin, B. W., ... Tsai, S. J. (2017). Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness. Cancer Research, 77(16), 4305-4316. https://doi.org/10.1158/0008-5472.CAN-16-2990

Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness. / Hou, Pei Chi; Li, Yo Hua; Lin, Shih Chieh; Lin, Shau Chieh; Lee, Jenq Chang; Lin, Bo Wen; Liou, Jing Ping; Chang, Jang Yang; Kuo, Ching Chuan; Liu, Yi Min; Sun, H. Sunny; Tsai, Shaw Jenq.

In: Cancer Research, Vol. 77, No. 16, 15.08.2017, p. 4305-4316.

Research output: Contribution to journalArticle

Hou, PC, Li, YH, Lin, SC, Lin, SC, Lee, JC, Lin, BW, Liou, JP, Chang, JY, Kuo, CC, Liu, YM, Sun, HS & Tsai, SJ 2017, 'Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness', Cancer Research, vol. 77, no. 16, pp. 4305-4316. https://doi.org/10.1158/0008-5472.CAN-16-2990
Hou, Pei Chi ; Li, Yo Hua ; Lin, Shih Chieh ; Lin, Shau Chieh ; Lee, Jenq Chang ; Lin, Bo Wen ; Liou, Jing Ping ; Chang, Jang Yang ; Kuo, Ching Chuan ; Liu, Yi Min ; Sun, H. Sunny ; Tsai, Shaw Jenq. / Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness. In: Cancer Research. 2017 ; Vol. 77, No. 16. pp. 4305-4316.
@article{ddb7b63e6952458f8dba47c1424f76ca,
title = "Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness",
abstract = "Cancer stem-like cells (CSC) evolve to overcome the pressures of reduced oxygen, nutrients or chemically induced cell death, but the mechanisms driving this evolution are incompletely understood. Here, we report that hypoxia-mediated downregulation of the dual specificity phosphatase 2 (DUSP2) is critical for the accumulation of CSC in colorectal cancer. Reduced expression of DUSP2 led to overproduction of COX-2–derived prostaglandin E2, which promoted cancer stemness via the EP2/EP4 signaling pathways. Genetic and pharmacological inhibition of PGE2 biosynthesis or signal transduction ameliorated loss-of-DUSP2–induced tumor growth and cancer stemness. Genome-wide profile analysis revealed that genes regulated by DUSP2 were similar to those controlled by histone deacetylase. Indeed, treatment with novel histone deacetylase inhibitors abolished hypoxia-induced DUSP2 downregulation, COX-2 overexpression, cancer stemness, tumor growth, and drug resistance. Our findings illuminate mechanisms of cancer stemness and suggest new cancer therapy regimens.",
author = "Hou, {Pei Chi} and Li, {Yo Hua} and Lin, {Shih Chieh} and Lin, {Shau Chieh} and Lee, {Jenq Chang} and Lin, {Bo Wen} and Liou, {Jing Ping} and Chang, {Jang Yang} and Kuo, {Ching Chuan} and Liu, {Yi Min} and Sun, {H. Sunny} and Tsai, {Shaw Jenq}",
year = "2017",
month = "8",
day = "15",
doi = "10.1158/0008-5472.CAN-16-2990",
language = "English",
volume = "77",
pages = "4305--4316",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "16",

}

TY - JOUR

T1 - Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness

AU - Hou, Pei Chi

AU - Li, Yo Hua

AU - Lin, Shih Chieh

AU - Lin, Shau Chieh

AU - Lee, Jenq Chang

AU - Lin, Bo Wen

AU - Liou, Jing Ping

AU - Chang, Jang Yang

AU - Kuo, Ching Chuan

AU - Liu, Yi Min

AU - Sun, H. Sunny

AU - Tsai, Shaw Jenq

PY - 2017/8/15

Y1 - 2017/8/15

N2 - Cancer stem-like cells (CSC) evolve to overcome the pressures of reduced oxygen, nutrients or chemically induced cell death, but the mechanisms driving this evolution are incompletely understood. Here, we report that hypoxia-mediated downregulation of the dual specificity phosphatase 2 (DUSP2) is critical for the accumulation of CSC in colorectal cancer. Reduced expression of DUSP2 led to overproduction of COX-2–derived prostaglandin E2, which promoted cancer stemness via the EP2/EP4 signaling pathways. Genetic and pharmacological inhibition of PGE2 biosynthesis or signal transduction ameliorated loss-of-DUSP2–induced tumor growth and cancer stemness. Genome-wide profile analysis revealed that genes regulated by DUSP2 were similar to those controlled by histone deacetylase. Indeed, treatment with novel histone deacetylase inhibitors abolished hypoxia-induced DUSP2 downregulation, COX-2 overexpression, cancer stemness, tumor growth, and drug resistance. Our findings illuminate mechanisms of cancer stemness and suggest new cancer therapy regimens.

AB - Cancer stem-like cells (CSC) evolve to overcome the pressures of reduced oxygen, nutrients or chemically induced cell death, but the mechanisms driving this evolution are incompletely understood. Here, we report that hypoxia-mediated downregulation of the dual specificity phosphatase 2 (DUSP2) is critical for the accumulation of CSC in colorectal cancer. Reduced expression of DUSP2 led to overproduction of COX-2–derived prostaglandin E2, which promoted cancer stemness via the EP2/EP4 signaling pathways. Genetic and pharmacological inhibition of PGE2 biosynthesis or signal transduction ameliorated loss-of-DUSP2–induced tumor growth and cancer stemness. Genome-wide profile analysis revealed that genes regulated by DUSP2 were similar to those controlled by histone deacetylase. Indeed, treatment with novel histone deacetylase inhibitors abolished hypoxia-induced DUSP2 downregulation, COX-2 overexpression, cancer stemness, tumor growth, and drug resistance. Our findings illuminate mechanisms of cancer stemness and suggest new cancer therapy regimens.

UR - http://www.scopus.com/inward/record.url?scp=85028350060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028350060&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-16-2990

DO - 10.1158/0008-5472.CAN-16-2990

M3 - Article

C2 - 28652251

AN - SCOPUS:85028350060

VL - 77

SP - 4305

EP - 4316

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 16

ER -